[2][3] Further, they share common practices on procedures, science, Laboratory Information Management Systems (LIMS), validation, quality (GLP) and discuss new developments in industry.
Views and recommendations following from these discussions are either published in scientific journals, like for example on the controversial and much debated topic of incurred sample reproducibility[4] or presented at international meetings.
The forum currently hosts two types of meetings: Twice a year the EBF brings together representatives all member companies to discuss subjects well prepared in advance.
The EBF organizes annual symposia to involve the bioanalytical community: pharmaceutical industry, academia, CRO, instrument providers and regulatory agencies.
It is the intention of the organisation to inform their business partners and peers about the discussion held and agreements achieved and to open the forum for challenging procedures or techniques as well as for new regulatory requirements.